Search research articles
Contact Us
Filters
Showing results (191-200 of 197) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 197 results.
Nature Communications
|
December 13, 2019
Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
Jerry H Houl, Zu Ye, Chris A Brosey, et al.
Nature Cancer
|
October 17, 2022
Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex
Yu-Yi Chu, Mei-Kuang Chen, Yongkun Wei, et al.
Nature Medicine
|
January 19, 2016
Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors
Yi Du, Hirohito Yamaguchi, Yongkun Wei, et al.
Nature Medicine
|
October 7, 2016
Corrigendum: Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors
Yi Du, Hirohito Yamaguchi, Yongkun Wei, et al.
American Journal of Cancer Research
|
May 11, 2023
Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells
Lei Nie, Ying-Nai Wang, Jung-Mao Hsu, et al.
The Journal of Clinical Investigation
|
June 3, 2025
FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer models
Mei-Kuang Chen, Hirohito Yamaguchi, Yuan Gao, et al.
Ophthalmology
|
April 29, 2020
Prevalence and Pattern of Geographic Atrophy in Asia: The Asian Eye Epidemiology Consortium
Tyler Hyungtaek Rim, Ryo Kawasaki, Yih-Chung Tham, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 197) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 197 results.
Nature Communications
|
December 13, 2019
Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
Jerry H Houl, Zu Ye, Chris A Brosey, et al.
Nature Cancer
|
October 17, 2022
Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex
Yu-Yi Chu, Mei-Kuang Chen, Yongkun Wei, et al.
Nature Medicine
|
January 19, 2016
Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors
Yi Du, Hirohito Yamaguchi, Yongkun Wei, et al.
Nature Medicine
|
October 7, 2016
Corrigendum: Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors
Yi Du, Hirohito Yamaguchi, Yongkun Wei, et al.
American Journal of Cancer Research
|
May 11, 2023
Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells
Lei Nie, Ying-Nai Wang, Jung-Mao Hsu, et al.
The Journal of Clinical Investigation
|
June 3, 2025
FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer models
Mei-Kuang Chen, Hirohito Yamaguchi, Yuan Gao, et al.
Ophthalmology
|
April 29, 2020
Prevalence and Pattern of Geographic Atrophy in Asia: The Asian Eye Epidemiology Consortium
Tyler Hyungtaek Rim, Ryo Kawasaki, Yih-Chung Tham, et al.
Page
of 20